Transaction in Own Shares

Summary by AI BETAClose X

On September 10, 2025, GSK plc, acting through its broker Merrill Lynch International, purchased 213,147 of its own ordinary shares with a nominal value of 31¼ pence each. The lowest price paid per share was 1,480.50p, while the highest price reached 1,500.00p, resulting in a volume-weighted average price of 1,486.77p. These shares will be held as treasury shares as part of an existing buyback program, bringing the total purchased since June 4, 2025, to 28,232,207 ordinary shares. Following this transaction, GSK will hold 246,366,590 ordinary shares in treasury, with 4,069,035,137 ordinary shares in issue, excluding treasury shares; the treasury shares represent 6.05 percent of voting rights.

Disclaimer*

Companies

GSK (GSK)
UK 100

Latest directors dealings